D.E. Shaw & Co’s Oscar Health OSCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.98M Sell
96,700
-12,000
-11% -$369K ﹤0.01% 2893
2026
Q2
$3.1M Sell
108,700
-822,000
-88% -$17.7M ﹤0.01% 2813
2026
Q1
$10.7M Buy
930,700
+270,700
+41% +$3.81M 0.01% 1580
2025
Q4
$9.48M Sell
660,000
-149,300
-18% -$2.58M 0.01% 1804
2025
Q3
$15.3M Buy
+809,300
New +$13.3M 0.01% 1363
2023
Q1
– Sell
-60,000
Closed -$148K – 4747
2022
Q4
$148K Hold
60,000
– – ﹤0.01% 4319
2022
Q3
$299K Hold
60,000
– – ﹤0.01% 4302
2022
Q2
$255K Hold
60,000
– – ﹤0.01% 4433
2022
Q1
$598K Hold
60,000
– – ﹤0.01% 4258
2021
Q4
$471K Buy
+60,000
New +$753K ﹤0.01% 4439

Other funds holding OSCR

D.E. Shaw & Co's OSCR Position: Q3 2026 in Review

D.E. Shaw & Co increased its Oscar Health (OSCR) stake by 4.9% in Q3 2026, buying an estimated $19.1M and bringing the position to 13,263,965 shares worth $409M. The position accounts for 0.2% of the portfolio, ranked #99.

D.E. Shaw & Co first reported a position in OSCR in Q1 2022 and has held it in 18 quarters since. 422 funds tracked by Wall St. Rank hold OSCR as of Q3 2026.

  • D.E. Shaw & Co held 13,263,965 shares of Oscar Health worth $409M as of Q3 2026.
  • D.E. Shaw & Co bought 620,348 Oscar Health shares in Q3 2026, an estimated $19.1M.
  • Oscar Health made up 0.2% of D.E. Shaw & Co's portfolio in Q3 2026, its #99 holding.
  • D.E. Shaw & Co first reported a position in Oscar Health in Q1 2022 and has held it in 18 quarters since.
  • 422 funds tracked by Wall St. Rank held Oscar Health as of Q3 2026.

Based on D.E. Shaw & Co's 13F filing for Q3 2026, filed 16 Nov 2026.